The present invention is directed to the use of certain pyrido [1,2-a] -pyrazine derivatives, also described as bis-azabicyclic compounds and defined in the description by formula (I), in the treatment of Parkinson's disease, a disorder representing hyperactivity in impaired attention, and microadenomas in mammals, as well as on relevant compositions. The international application was published along with an international search report.
展开▼
